e-learning
resources
Munich 2014
Sunday, 07.09.2014
The assessment of comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Left heart dysfunction in acute exacerbation of COPD: Only risk factor or even outcome?
S. Goyal, U. Gampala, D. Srinath, N. Arcot (Chennai, India)
Source:
International Congress 2014 – The assessment of comorbidities
Session:
The assessment of comorbidities
Session type:
Thematic Poster Session
Number:
982
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Goyal, U. Gampala, D. Srinath, N. Arcot (Chennai, India). Left heart dysfunction in acute exacerbation of COPD: Only risk factor or even outcome?. Eur Respir J 2014; 44: Suppl. 58, 982
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Non invasive ventilation in acute respiratory failure due to COPD vs non COPD conditions: Effectiveness and failure predictors
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
Chronic obstructive pulmonary disease and sudden cardiac death: The Rotterdam study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015
Cardiovascular comorbidity predictors of survival in patients with COPD hypercapnic acute respiratory failure
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016
High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
Acute myocardial infarction among Spanish adults with and without COPD: Cumulative incidence and outcomes
Source: International Congress 2014 – COPD markers
Year: 2014
Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Acute phase reactants as predictors for hospital mortality in acute respiratory failure due to COPD exacerbation
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
COPD and co-existent chronic heart failure (CHF): Response to pulmonary rehabilitation (PR)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016
Episodes of Acute Respiratory Deterioration in patients with idiopathic pulmonary fibrosis in the UK – mortality and contributing factors
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF)
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Physical activity after discharge following chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF) exacerbations
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
Dyspnea Differentiation Index in patients with chronic obstructive pulmonary disease and congestive heart failure: a validation analysis
Source: Eur Respir J 2006; 28: Suppl. 50, 405s
Year: 2006
NIV for acute respiratory failure: The role of patient selection in hospital mortality
Source: International Congress 2014 – Expanding the use of noninvasive ventilation in acute respiratory failure
Year: 2014
Outcome predictors of noninvasive ventilation in patients with respiratory failure due to chronic obstructive pulmonary disease
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016
Possible risk factors for early and late NIV failure
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016
Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
Predictive factors of mortality in patients with chronic respiratory failure
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept